Status:
UNKNOWN
London Investigation Into diElectric Scanning of Lesions
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Collaborating Sponsors:
Micrima, Ltd.
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The MARIA breast imaging system is a novel CE-marked radio-frequency (RF) medical imaging device. The system employs an electromagnetic imaging technique that exploits the dielectric contrast between ...
Detailed Description
The early diagnosis of breast cancer is of paramount importance, with a 5-year survival rate of 97% if the cancer is caught "locally", deteriorating to 79% if it has progressed to the "axillary" lymph...
Eligibility Criteria
Inclusion
- Attending a symptomatic breast care clinic OR Patients who have a diagnosed or suspected breast cancer (P5/M5/U5/B5).
- Female sex
- 18 years or older.
- Able to provide informed consent.
- Not in any identified, vulnerable group.
Exclusion
- Unable to mount MARIA™ patient bed using provided 2-step
- Unable to lie in the prone position
- Patients who have undergone biopsy less than 5 days before the MARIA™ scan
- Patients with implanted electronics.
- Patients with breast implants.
- Patients with nipple piercings (unless they are removed prior to the MARIA™ scan)
- Breast sizes smaller than 197ml or greater than 1L in volume
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
994 Patients enrolled
Trial Details
Trial ID
NCT03302819
Start Date
November 1 2017
End Date
December 1 2018
Last Update
October 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.